How to Respond to FDA Form 483s and Warning Letters
July 10, 2017
Many medical device manufacturers receive FDA warning letters due to lack of preparation for the FDA inspection and/or an inadequate response to an FDA Form 483.
The manner in which manufacturers respond to the 483 is critical in mitigating potential compliance risks and preventing the issuance of a warning letter. This article by NSF’s Kristen Grumet, published in Medical Design and Outsourcing, explains six key steps manufacturers can take when issued the FDA Form 483.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Awards World-First Community Catch Certification to Orkney Crab Fishery
July 13, 2026Milestone certification sets a new benchmark for small-scale fishery sustainability and social responsibility.
NSF To Offer In-Person GMP and Regulatory Compliance Courses at SupplySide Global 2026
July 13, 2026NSF is offering a comprehensive GMP and regulatory compliance training program of classroom-based courses for dietary supplement industry professionals at SupplySide Global 2026.
NSF Issues First-Ever MSC Certification for an Eel Fishery to Perupez S.A.C. and Sakana del Peru
June 19, 2026Third-party certification plays a key role in independently verifying the sustainability of seafood operations.
iNADO Partners with NSF to Support Members and Athletes
May 27, 2026iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve